From last report: "The Company has negative working capital, liabilities that exceed its assets and significant cash flow deficiencies. Additionally, the Company will need significant funding for future operations and the expenditures that will be required to conduct the clinical and regulatory work to develop the Company’s product candidates. ... There is no assurance that the Company will be successful in obtaining the necessary funding to meet its business objectives. "
You must be new to the ADMP world. Their financial sheet has been horrible for years. The run up is pure speculation and based on the intellectual property rights. ADMP will never bring a product to market. A sale of assets is the only hope. If you're looking for $0.05 anytime soon........get the hell out.
Welcome to the REAL WORLD of Pharmaceuticals! Show me one that didn't start the same way????? I've been in this type of market for over 30 years and they are hard to find the right ones. SO MANY have great products developed, but the FDA makes their life miserable to protect other companies. Its a dirty business, feast or famine. Jury still out on this, but their prospects look GREAT!